Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Grand Rapids MI,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting
New

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

for
HER2-negative Breast Cancer, Hormone Receptor Positive Tumor,
Location: Detroit MI, Mount Clemens MI, Clarkston MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07227831

Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Detroit MI, Columbus OH, Cincinnati OH, Chicago IL,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase1, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Detroit MI, Cleveland OH, Grand Rapids MI, Toronto,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase1, Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

for
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Location: Detroit MI, Columbus OH, Madison WI, Baltimore MD,
Sponsor: TopAlliance Biosciences

Sex: All

Age: 18+

Code: NCT04137900

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Detroit MI, Troy MI, Cleveland OH, Grand Rapids MI,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase1, Phase2, Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Detroit MI, Newark DE, Iowa City IA, Hackensack NJ,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase1, Phase2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

for
Non-Small Cell Lung Cancer
Location: Detroit MI, Ann Arbor MI, Cleveland OH, London,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT05899608

Phase3, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Detroit MI, Arlington Heights IL, Lake Barrington IL,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05413421

Phase1, Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Detroit MI, Cleveland OH, Columbus OH, Zion IL,
Sponsor: J-Pharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07265674

Phase3, Recruiting

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

for
Light Chain (AL) Amyloidosis
Location: Detroit MI, Milwaukee WI, Boston MA, Duarte CA
Sponsor: Sorrento Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04316442

Phase1, Phase2, Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Detroit MI, Farmington Hills MI, Flint MI, Carmel IN,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT05646316

Phase3, Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

for
Chronic Phase Chronic Myelogenous Leukemia
Location: Detroit MI, Buffalo NY, Milwaukee WI, New York NY,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT04838041

Phase2, Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Detroit MI, Indianapolis IN, Charlottesville VA,
Sponsor: Dipenkumar Modi

Sex: All

Age: 18+

Code: NCT05852717

Phase2, Recruiting

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

for
Muscular Diseases, Neuromuscular Manifestations, Autoimmune,
Location: Detroit MI, Columbus OH, Philadelphia PA, New York NY,
Sponsor: Arcellx, Inc.

Sex: All

Age: 18+

Code: NCT06626919

Phase1, Recruiting

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

for
Head and Neck Squamous Cell Carcinoma
Location: Detroit MI, Detriot MI, Cleveland OH, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06163534

Recruiting

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

for
Advanced Adenocarcinoma
Location: Detroit MI, Cleveland OH, Cincinnati OH, Chicago IL,
Sponsor: BioAtla, Inc.

Sex: All

Age: 18+

Code: NCT05808634

Phase1, Recruiting

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma,
Location: Detroit MI, Lake Success NY, Dallas TX, Houston TX,
Sponsor: PanTher Therapeutics

Sex: All

Age: 18+

Code: NCT06673017

Phase1, Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Detroit MI, Maumee OH, Columbus OH, Indianapolis IN,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase1, Phase2, Recruiting